DBR1

DBR1. DBR1 is a highly conserved RNA lariat debranching enzyme that is essential for the processing of intron lariats generated during pre-mRNA splicing. By cleaving the unique 2'-5' phosphodiester bond at the branch point, it linearizes the excised lariat structure, allowing its subsequent degradation and the recycling of nucleotides. This enzymatic activity is a critical and non-redundant step in the RNA metabolism pathway, with functional orthologs identified across diverse eukaryotic organisms, from yeast to humans.

Structure and Function

The DBR1 protein is characterized by a central divalent metal ion-dependent hydrolase domain that belongs to the phosphodiesterase family. Structural studies, often utilizing X-ray crystallography on enzymes from model organisms like Schizosaccharomyces pombe, reveal a conserved active site that specifically recognizes and binds the branch point adenosine within the lariat's three-dimensional structure. Its enzymatic mechanism involves a nucleophilic attack on the 2'-5' phosphodiester bond, resulting in a linear RNA product with a 5'-phosphate and a 3'-hydroxyl terminus. This linearization is a prerequisite for the subsequent action of exoribonucleases such as the exosome complex and XRN1, which complete the RNA turnover process.

Discovery and Nomenclature

The gene encoding the debranching enzyme was first identified and characterized through genetic screens in the budding yeast Saccharomyces cerevisiae in the late 1980s. Mutants lacking this activity, termed *dbr1* (de*branching* enzyme deficient), were found to accumulate intron lariats, providing direct evidence for its biological role. The nomenclature DBR1 has been consistently adopted across eukaryotic species. The human ortholog was later cloned by complementation of the yeast mutant, confirming the high degree of functional conservation from yeast to humans.

Role in DNA Repair

While primarily associated with RNA metabolism, DBR1 activity has been implicated in certain DNA repair pathways, particularly in the maintenance of genomic stability. Research indicates that unresolved RNA lariats can interfere with DNA replication forks and transcription, potentially leading to DNA damage. Furthermore, studies in systems like the African clawed frog (*Xenopus laevis*) egg extract have suggested a role for debranching in processing RNA-DNA hybrids that may form during repair processes. Its function is therefore seen as supportive, ensuring that aberrant RNA structures do not become obstacles for critical DNA transactions monitored by complexes like the MRE11–RAD50–NBS1 complex.

Clinical Significance

Mutations in the *DBR1* gene have been linked to a specific form of severe viral encephalitis. In 2017, researchers from the National Institutes of Health and the Rockefeller University discovered that autosomal recessive loss-of-function mutations in *DBR1* confer susceptibility to infections from herpes simplex virus 1 and influenza virus. The proposed mechanism involves the accumulation of un-debranched intron lariats, which may sequester essential immune proteins or disrupt the expression of interferon-stimulated genes required for antiviral defense. This discovery highlights a novel link between a fundamental RNA processing enzyme and innate immunity.

Research and Applications

DBR1 is a subject of ongoing research in molecular biology and virology. Its essential role makes it a potential target for antifungal agents, as demonstrated in studies targeting the Candida albicans enzyme. In biotechnology, understanding lariat turnover is important for optimizing systems like yeast display and recombinant protein production. Furthermore, investigating the *DBR1*-associated encephalitis pathway may lead to new therapeutic strategies for managing severe viral infections. Research often employs model systems such as the zebrafish and patient-derived fibroblast cell lines to dissect the complex interplay between RNA processing and host–pathogen interaction. Category:RNA-binding proteins Category:Enzymes Category:Human proteins